Pharma’s digital health ambitions: Where are the opportunities and what’s hindering progress?

A panel discussion on the future of digital health in pharma at the MedCity CONVERGE conference in Philadelphia this week highlighted how Pfizer, Eli Lilly and Roche are using telemedicine, mobile health and connected devices as part of their drug development strategy. They also called attention to the impact of compliance on implementing these technologies.

See it on Scoop.it, via Digital Health

from Digital Health | Scoop.it http://www.scoop.it/t/health-care-social-media/p/4066284835/2016/07/12/pharma-s-digital-health-ambitions-where-are-the-opportunities-and-what-s-hindering-progress
via IFTTT